Galina S. Marder

Galina S. Marder

Rheumatology

865 Northern Boulevard
Suite 302
Great Neck, NY 11021

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

Journal: The New England journal of medicine

Published: March 30, 2026

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

Journal: The New England journal of medicine

Published: March 30, 2026

Real-world experience with obinutuzumab in difficult-to-treat myositis: concise report of a case series.

Real-world experience with obinutuzumab in difficult-to-treat myositis: concise report of a case series.

Journal: Rheumatology (Oxford, England)

Published: February 23, 2026

Abatacept for the treatment of myositis-associated interstitial lung disease.

Abatacept for the treatment of myositis-associated interstitial lung disease.

Journal: Rheumatology (Oxford, England)

Published: February 07, 2025

Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease.

Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease.

Journal: Rheumatology (Oxford, England)

Published: June 20, 2024

Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease.

Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease.

Journal: RMD open

Published: May 31, 2024

Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases.

Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases.

Journal: JCI insight

Published: February 29, 2024

Clinical Use of Belimumab for Systemic Lupus Erythematosus in the Setting of Advanced Chronic Kidney Disease and End-Stage Kidney Disease on Dialysis: A Case Series.

Clinical Use of Belimumab for Systemic Lupus Erythematosus in the Setting of Advanced Chronic Kidney Disease and End-Stage Kidney Disease on Dialysis: A Case Series.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: August 25, 2023

The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.

The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.

Journal: Seminars in arthritis and rheumatism

Published: June 01, 2023

Belimumab treatment of adult idiopathic inflammatory myopathy.

Belimumab treatment of adult idiopathic inflammatory myopathy.

Journal: Rheumatology (Oxford, England)

Published: March 07, 2023

Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis.

Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis.

Journal: ACR open rheumatology

Published: January 27, 2022

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry.

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry.

Journal: Blood

Published: December 21, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026